Eicosapentaenoic acid has a preventive effect on the recurrence of nephrolithiasis

Urologia Internationalis

Volumn 81, Issue 2, 2008, Pages 135-138

  Yasui, Takahiro ^a   Suzuki, Sadao ^a   Itoh, Yasunori ^a   Tozawa, Keiichi ^a   Tokudome, Shinkan ^a   Kohri, Kenjiro ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Calcium oxalate; Eicosapentaenoic acid; Nephrolithiasis; Recurrent stone formation

Indexed keywords

CALCIUM OXALATE; EPADEL; ICOSAPENTAENOIC ACID; UNCLASSIFIED DRUG;

ADULT; AGED; ARACHIDONIC ACID METABOLISM; ARTICLE; ATHEROSCLEROSIS; CALCIUM STONE; CLINICAL ARTICLE; DRUG EFFECT; FAT INTAKE; FEMALE; HUMAN; HYPERLIPIDEMIA; MALE; NEPHROLITHIASIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RECURRENT DISEASE; RISK REDUCTION; STOMACH DISCOMFORT; STONE FORMATION;

ADULT; AGED; CALCIUM; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; INCIDENCE; JAPAN; KIDNEY CALCULI; MALE; MIDDLE AGED; RECURRENCE;

EID: 50849108809     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000144050     Document Type: Article

References (14)

1. Pak CY: Kidney stones. Lancet 1998;351:1797-1801.
2. Baggio B, Gambaro G: Abnormal arachidonic acid content of membrane phospholipids - the unifying hypothesis for the genesis of hypercalciuria and hyperoxaluria in idiopathic calcium nephrolithiasis. Nephrol Dial Transplant 1999;14:553-555.
3. Donadio JV: n-3 fatty acids and their role in nephrologic practice. Curr Opin Nephrol Hypertens 2001;10:639-642.
4. Kromhout D, Bosschieter EB, Coulander CL: The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985;312:1205-1209.
5. Yetiv JZ: Clinical applications of fish oils. JAMA 1988;260:665-670.
6. Buck AC, Davies RL, Harrison T: The protective role of eicosapentaenoic acid in the pathogenesis of nephrolithiasis. J Urol 1991;146:188-194.
7. Yoshida O, Terai A, Ohkawa T, Okada Y: National trend of the incidence of urolithiasis in Japan from 1965 to 1995. Kidney Int 1999;56:1899-1904.
8. Yasui T, Tanaka H, Fujita K, Iguchi M, Kohri K: Effects of eicosapentaenoic acid on urinary calcium excretion in calcium stone formers. Eur Urol 2001;39:580-585.
9. Hosking DH, Erickson SB, Van-den-Berg CJ, Wilson DM, Smith LH: The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urol 1983;130:1115-1118.
10. Liscovitch M, Cantley LC: Lipid second messengers. Cell 1994;77:329-334.
11. Buck AC, Lote CJ, Sampson WF: The influence of renal prostaglandins on urinary calcium excretion in idiopathic urolithiasis. J Urol 1983;129:421-426.
12. Davidson J, Rotondo D: Lipid metabolism. Curr Opin Lipidol 2002;13:339-341.
13. Baggio B, Budakovic A: Fatty acids and idiopathic calcium nephrolithiasis. Urol Int 2005;75:97-101.
14. Taylor EN, Stampfer MJ, Curhan GC: Fatty acid intake and incident nephrolithiasis. Am J Kidney Dis 2005;45:267-274.